Comparison of the disc diffusion assay with spectrophotometer technique for antibacterial activity of diclofenac sodium, indomethacin and mefenamic acid

Asian Journal of Pharmaceutics

Volumn 3, Issue 2, 2009, Pages 148-152

  Al Janabi, Ali Abdul Hussein ^a  

^a UNIVERSITY OF KERBALA   (Iraq)

Author keywords

Diclofenac sodium; Indomethacin; Mefenamic acid; Spectrophotometer

Indexed keywords

DICLOFENAC; INDOMETACIN; MEFENAMIC ACID;

ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACILLUS SUBTILIS; BACTERIAL STRAIN; CONCENTRATION RESPONSE; CONTROLLED STUDY; DISK DIFFUSION; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ESCHERICHIA COLI; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PARACOCCUS; SALMONELLA TYPHI; SPECTROPHOTOMETRY; STAPHYLOCOCCUS AUREUS;

EID: 77953440142     PISSN: 09738398     EISSN: 1998409X     Source Type: Journal    
DOI: 10.4103/0973-8398.55054     Document Type: Article

References (16)

1. Paje ML, Kuhlicke U, Winkler M, Neu TR. Inhibition of lotic biofilms by diclofenac. App Microbiol Biotechnol 2002;59:488-92.
2. nd ed. PhP. U.S.A: 1999.
3. Dutta NK, Mazumdar K, Baek MW, Kim DJ. in vitro efficacy of diclofenac against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 1999;27:315-9.
4. Mazumdar K, Dutta NK, Dastidar SG, Motohashi N, Shirataki Y. Diclofenac in the management of E. coli urinary tract infections. In vivo 2006;20:613-3.
5. Dutta NK, Dastidar SG, Kumar A, Mazumdar K, Ray R, Chakrabarty AN. Antimycobacterial activity of the anti-inflammatory agent diclofenac sodium, and its synergism with streptomycin. Braz J Microbiol 2004;35:316-323.
6. Zhang Y, Zhang H, Sun Z. Susceptibilty of Mycobacterium tuberculosis to weak acids. J Antimicrob Chemother 2003;52:56-60.
7. Dalby AB, Frank DN, St. Amand AL, Bendele AM, Pace NR. Culture- Independent analysis of indomethacin-induced alterations in the rat gastrointestinal microbiota. Appl Environ Microbiol 2006;72:6707-15.
8. Linder H, Engberg I, van Kooten C, de Man P, Svanborg-Eden C. Effects of anti-inflammatory agents on mucosal inflammation induced by infection with gram-negative bacteria. Infect Immun 1990;58:2056-60.
9. Van der Flier M, Geelen SP, Kimpen JL. Anti-inflammatory adjuvant agents in bacterial meningitis. Curr Med Chem 2002;1:55-62.
10. National Committee for Clinical Laboratory Standards. Performance Standards for Antimicrobial Disk Sususceptibility Test: Approved Standard M2-A6.NCCLS.Wayne, PA: 1997.
11. Domínguez MC, de la Rosa M, Borobio MV. Application of a spectrophotometric method for the determination of post-antibiotic effect and comparison with viable counts in agar. J Antimicrob Chemother 2001;47:391-8.
12. NCCLS. Methods for dilution antimicrobial susceptibility testing for bacteria that grow aerobically; approved standard-sixth edition. NCCLS document M7-A6. NCCLS, Wayne. Pennsylvania: 2003.
13. Kruszewska H, Zareba T, Tyski S. Estimation of antimicrobial activity of selected non-antibiotic products. Acta Pol Pharm 2006;63:457-60.
14. Fuchs PC, Barry AL, Brown SD. Comparative in vitro antimicrobial activity of a new carbapenem, E1010, and tentative disc diffusion test interpretative criteria. J Antimicrob Chemother 2001;48:23-8.
15. Derle DV, Bele M, Kasliwal N. in vitro and in vivo evaluation of mefenamic acid and its complexes with β-cyclodexin and HP-β- cyclodexin. Asian Journal of Pharmaceutics 2008;21:30-35.
16. Kowalczyk E, Kopff A, Blaszczyk J, Fijalkowski P, Kopff M. The influence of selected nonsteroidal anti-inflammatory drugs on antioxidative enzymes activity. Pol Arch Med Wewn 2006:115:112-7. (Pubitemid 44047452)